Data across Brachyury and NONO programs validate Talus Bio’s regulome sequencing platform across multiple targets, supporting a ...

Data I/O’s EPS and revenue both missed analyst forecasts. Global bookings increased by 7% year-over-year, indicating demand ...

Net income surged to $16.8 million, largely due to the CloudFirst sale. Stock price increased by 5.91% following the earnings ...

I believe that understanding what drives consumer choices is the bedrock of successful product development. But let's be honest ...